254 related articles for article (PubMed ID: 33426698)
1. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
3. [CD103
Li BW; Ren SQ; Chen SL; Lan TJ; Wu F; Li JS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Dec; 58(12):1257-1264. PubMed ID: 38061868
[No Abstract] [Full Text] [Related]
4. Preoperative Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Oral Squamous Cell Carcinoma: A Large-Sample Prospective Study.
Chen F; Lin L; Yan L; Qiu Y; Cai L; He B
J Oral Maxillofac Surg; 2017 Jun; 75(6):1275-1282. PubMed ID: 28011326
[TBL] [Abstract][Full Text] [Related]
5. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
6. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
7. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients: a comparison study.
Zhou T; Yu ST; Chen WZ; Xie R; Yu JC
J Cancer; 2019; 10(3):594-601. PubMed ID: 30719156
[No Abstract] [Full Text] [Related]
9. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study on the potential of albumin/globulin ratio as a prognostic biomarker for oral cavity cancer patients.
Wang YT; Fang KH; Hsu CM; Chang GH; Lai CH; Lee YC; Tsai MS; Huang EI; Tsai YT
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):227-238. PubMed ID: 32583177
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Prognosis of Oral Squamous Cell Carcinoma.
Tazeen S; Prasad K; Harish K; Sagar P; Kapali AS; Chandramouli S
J Oral Maxillofac Surg; 2020 Jun; 78(6):949-960. PubMed ID: 32027861
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
14. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.
Wang S; Feng Y; Xie Y; Zhao X; Ma J; Liu X; Hu C; Hou T
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4541-4548. PubMed ID: 35462579
[TBL] [Abstract][Full Text] [Related]
15. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative systemic inflammatory response as a prognostic indicator in patients with early-stage oral squamous cell carcinoma.
Mikami T; Funayama A; Niimi K; Haga K; Kawaharada M; Nakamura A; Katagiri W; Kobayashi T
Medicine (Baltimore); 2022 Nov; 101(44):e30855. PubMed ID: 36343034
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
[TBL] [Abstract][Full Text] [Related]
20. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
